AI assistant
Sending…
NeuroPace Inc — Director's Dealing 2021
Nov 2, 2021
33194_dirs_2021-11-02_4844b639-5d8e-465a-aaf9-fa4f28809f0d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2021-11-01
Reporting Person: Andrade Lisa (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-01 | Stock Option (Right to Buy) | $15.63 | A | 11836 | Acquired | 2031-10-31 | Common Stock (11836) | Direct |
Footnotes
F1: 1/36th of the shares subject to the option vest in equal monthly installments commencing December 1, 2021
More from NeuroPace Inc
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 21
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 4
Annual Report
2026
Mar 3
Regulatory Filings
2026
Mar 3
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 23